Welcome to kongre.net
Speaker
Chief Business & Strategy Officer, Parabilis Medicines
Helen Ho, Chief Business & Strategy Officer at Parabilis Medicines, spoke at Oncology & Immunology Innovation Partnering & Licensing Summit (Boston, United States of America, 9–10 Sept 2026) in the session “From Platform Potential to Deal Reality: Aligning Modality, Targets & Evidence”.
9–10 Sept 2026Boston, United States of America
Director, Oncology Search & Evaluation, Business Development & Licensing, Merck & Co
Global Director, Research & Technology Search & Evaluation, Daiichi Sankyo
Science Partner, Flagship Pioneering
Search & Evaluation Lead, GI & Inflammation, Strategy & Portfolio Development, Takeda Pharmaceutical
Chief Business Officer, Nurix Therapeutics, Inc.
Head of Search and Evaluation - Respiratory and Immunology, AstraZeneca
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Helen Ho, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].